LIMA1 and breast cancer: Interestingly, nutlin-3a treatment of wild-type, but not p53-mutated cells, also enhanced EPLIN protein expression without impacting on p63 or p73 expression in MCF7 breast cancer, LoVo colon cancer and A549 lung cancer cells, implicating p53 in inducing EPLIN protein expression.